Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dopamine receptor D5 subtype (D5R) is a G protein-coupled receptor of the D1-like dopamine receptor family, encoded by the DRD5 gene in humans[1][2]. D5R has roughly 10-fold higher affinity for dopamine compared to the D1 receptor[1]. Upon activation, D5R stimulates adenylyl cyclase, leading to increased intracellular cAMP through Gαs/olf protein coupling[1][2]. D5R is highly expressed in cortical brain regions and plays a critical role in regulating learning and memory, neuronal oscillatory activity, and cognitive processes[4]. Dysfunction or altered signaling through D5R is implicated in cognitive impairment and potentially other neuropsychiatric conditions[4]. Pharmacological targeting of D5R may modulate brain-derived neurotrophic factor and protein kinase B signaling[1][4]. Few ligands distinguish D5R reliably from D1R due to their close homology, making highly selective drugs difficult to develop[1][4].
Agonists mimic dopamine action, activating the receptor, promoting cAMP synthesis via Gαs/olf signaling. Antagonists/inverse agonists block receptor activation or induce opposite signaling effects.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine receptor D5 subtype (D5R).